Evidence map›Paper›PMID 41269469›Full record

ReviewCurrent nutrition reports2025

Poor Vision from Copper Deficiency.

Leslie M Klevay

Abstract readReview
In one paragraph

Review in Current nutrition reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Leslie M KlevayUniversity of North Dakota School of Medicine and Health Sciences, 1301 North Columbia Rd, Grand Forks, ND, 58202-9037, USA. leslie.klevay@ndus.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA dozen medical articles describe poor vision from copper deficiency. They are collected here along with some ideas about copper nutrition, epidemiology, patient evaluation and treatment. RECENT

findingsClinical descriptions have been brief. Severe vision loss of a middle-aged woman improved from 20/400 to 20/25 with copper replacement for 10 months. The optimal chemical form, dose, duration or route of copper repletion are defined poorly. Copper gluconate is the preferred supplement; several mg of elemental copper usually should be given daily for months. Superoxide dismutase in erythrocytes is one of the more sensitive tests of deficiency.

Indexed as

CopperVision DisordersDietary SupplementsFemaleHumansMiddle AgedCopperCopper deficiencyDiagnostic testsDietary copperOptic neuropathyVision loss

Identifiers

PMID41269469
PMCPMC12638359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.